EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ameliorative Effect of Tirzepatide on Obesity-Induced Salivary Gland Injury in a Rat Model: Associated with Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Anti-Fibrotic Effects

Enas N. Morgan, Ayman M. Mousa

Life · 20.11.2026 · 16 (11) · 1968

DOI: 10.3390/life16111968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 20.11.2026. Verfasst von Enas N. Morgan und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Graduate Studies and Scientific Research at Qassim University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic disorders from a high-fat diet impair salivary gland integrity, and the effect of tirzepatide on these glands is unknown. We investigated tirzepatide’s effects on high-fat diet (HFD)-induced salivary gland injury in rats. Forty adult male rats were randomly assigned to four groups: control (G1), HFD-fed (G2), HFD + saline (G3), and HFD + tirzepatide (G4). We assessed metabolic parameters, oxidative stress markers, inflammatory cytokines (TNF-α, IL-1β), caspase-3 concentration, stimulated salivary flow rate (SSFR), histopathology, and mast cell morphometry. HFD feeding caused insulin resistance and dyslipidemia, increased oxidative stress, TNF-α, IL-1β, and caspase-3 in salivary gland homogenate, histological damage to salivary gland tissue, increased mast cell indices, and collagen deposition. Tirzepatide significantly improved metabolic abnormalities and attenuated oxidative stress and inflammation, reduced caspase-3, mast cell, and fibrotic changes, and preserved salivary gland structure. SSFR showed no significant differences in pairwise comparisons. HFD-fed groups (G2 and G3) showed a reduced stimulated salivary rate per 100 g body weight (mL/15 min/100 g BW) compared with the control (G1). The tirzepatide-treated group (G4) had an improved stimulated salivary rate per 100 g BW, with no significant difference from the control (G1). The data suggest that tirzepatide ameliorates HFD-induced salivary gland injury, and this effect was associated with reduced oxidative stress, inflammatory cytokine levels (TNF-α, IL-1β), and caspase-3. The preservation of absolute SSFR despite marked tissue damage suggests that structural damage may occur without a concomitant reduction in overall stimulated salivary secretion.

Förderung

  • Deanship of Graduate Studies and Scientific Research at Qassim University

Zitieren

APA

Morgan, E. N., & Mousa, A. M. (2026). Ameliorative Effect of Tirzepatide on Obesity-Induced Salivary Gland Injury in a Rat Model: Associated with Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Anti-Fibrotic Effects. Life, 16(11), 1968. https://doi.org/10.3390/life16111968

Vancouver

Morgan EN, Mousa AM. Ameliorative Effect of Tirzepatide on Obesity-Induced Salivary Gland Injury in a Rat Model: Associated with Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Anti-Fibrotic Effects. Life. 2026;16(11):1968. doi:10.3390/life16111968

BibTeX
@article{Morgan2026,
  author = {Morgan, Enas N. and Mousa, Ayman M.},
  title = {Ameliorative Effect of Tirzepatide on Obesity-Induced Salivary Gland Injury in a Rat Model: Associated with Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Anti-Fibrotic Effects},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1968},
  doi = {10.3390/life16111968}
}
Kostenlos starten →